Founder & COOJon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Nektar Therapeutics (NASDAQ:NKTR) reported mixed Phase 2b results for rezpegaldesleukin in severe-to-very-severe alopecia areata, showing meaningful clinical activity but narrowly missing the trial’s primary endpoint in the modified intent-to-treat population.
Elbit Systems (NASDAQ:ESLT) said the Greek government has approved funding for the acquisition of its PULS rocket artillery system, clearing a major hurdle in a deal expected to result in a material contract for the Israeli defense company.
Bicycle Therapeutics (NASDAQ:BCYC), developer of a novel class of bicyclic peptide-based medicines, has secured a 15-year contract with the UK Nuclear Decommissioning Authority granting access to up to 400 tonnes of reprocessed uranium (RepU)—a resource the company says will underpin long-term production of lead-212 (212Pb) for its emerging cancer radioconjugate programs.
Resources & Energy Group (ASX:REZ) has raised $2 million through a placement of 142.86 million shares at $0.014 each
REA Group (ASX:REA) shares fell on Dec. 15 as global online real estate stocks reacted to Alphabet's Google testing a new search ad format that places homes-for-sale listings directly at the top of search results.
Sovereign Metals (ASX:SVM) has signed a strategic collaboration agreement with the International Finance Corporation
Audeara (ASX:AUA) has signed a software licensing cooperation agreement with Shenzhen-based system-on-chip design company OPTEK Microelectronics.
Innovative Industrial Properties (NYSE:IIPR), the leading real estate investment trust focused on regulated cannabis facilities, declared its fourth-quarter 2025 dividend of $1.90 per share of common stock, the company said Monday
Adecoagro (NASDAQ:AGRO) finalized the purchase of YPF’s 50% stake in Profertil for approximately $1.1 billion, securing a 90% controlling interest in South America’s largest granular urea producer, and is projected to nearly double its Adjusted EBITDA.
Royal Philips announced an agreement to acquire SpectraWAVE, a Boston-area medical device company, integrating its advanced HyperVue imaging and AI-enabled FFR technology into Philips’ image-guided therapy suite.
